Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity
US10016517B2 · kind B2 · utility
1Cited by
1References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 8, 2012 |
| Grant date | Jul 10, 2018 |
| Priority date | — |
| Expiry date | Jul 13, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/624
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to nanoparticle compositions and treatment of cardiovascular disease using nanoparticles to target Class A and B scavenger receptors. This invention further relates to methods of detecting cells that express scavenger receptors, detecting atherosclerotic lesions, and targeting bioactive amphiphilic macromolecules to cells that express scavenger receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.